WT
TPST icon

Whittier Trust’s Tempest Therapeutics TPST Stock Holding History

Whittier Trust’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Hold
0
– -$7 – 1593
2024
Q1 		– Hold
0
– – – 1509
2023
Q4 		– Sell
-1
Closed -$47 – 1505
2023
Q3 		$2 Hold
1
– – ﹤0.01% 1674
2023
Q2 		$15 Buy
+1
New +$25 ﹤0.01% 1559

Other funds holding TPST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Whittier Trust's TPST Position: Q2 2024 in Review

Whittier Trust held its Tempest Therapeutics (TPST) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1593.

Whittier Trust first reported a position in TPST in Q2 2023 and has held it in 2 quarters since. The position peaked at $15 in Q2 2023. 24 funds tracked by Wall St. Rank hold TPST as of Q2 2024.

  • Whittier Trust held 0 shares of Tempest Therapeutics worth $0 as of Q2 2024.
  • Whittier Trust left its Tempest Therapeutics share count unchanged in Q2 2024.
  • Tempest Therapeutics made up ﹤0.01% of Whittier Trust's portfolio in Q2 2024, its #1593 holding.
  • Whittier Trust first reported a position in Tempest Therapeutics in Q2 2023 and has held it in 2 quarters since.
  • Whittier Trust's Tempest Therapeutics position peaked at $15 in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2024.

Based on Whittier Trust's 13F filing for Q2 2024, filed 29 Jul 2024.